| Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT Y Sanli, I Garg, A Kandathil, T Kendi, MJB Zanetti, S Kuyumcu, ... American Journal of Roentgenology 211 (2), 267-277, 2018 | 171 | 2018 |
| Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors? DH Simsek, S Kuyumcu, C Turkmen, Y Sanlı, F Aykan, S Unal, I Adalet Journal of Nuclear Medicine 55 (11), 1811-1817, 2014 | 103 | 2014 |
| Physiological and tumoral uptake of 68Ga-DOTATATE: standardized uptake values and challenges in interpretation S Kuyumcu, ZG Özkan, Y Sanli, E Yilmaz, A Mudun, I Adalet, S Unal Annals of nuclear medicine 27, 538-545, 2013 | 95 | 2013 |
| Increased FDG uptake in breast cancer is associated with prognostic factors Y Sanli, S Kuyumcu, ZG Ozkan, G Işık, H Karanlik, B Guzelbey, ... Annals of nuclear medicine 26, 345-350, 2012 | 85 | 2012 |
| The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels Y Sanli, S Kuyumcu, ZG Ozkan, L Kilic, E Balik, C Turkmen, D Has, G Isik, ... Annals of nuclear medicine 26, 551-558, 2012 | 71 | 2012 |
| Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer Y Sanli, S Kuyumcu, O Sanli, F Buyukkaya, A İribaş, G Alcin, ... Annals of nuclear medicine 31, 709-717, 2017 | 61 | 2017 |
| Safety of fibroblast activation protein–targeted radionuclide therapy by a low-dose dosimetric approach using 177Lu-FAPI04 S Kuyumcu, B Kovan, Y Sanli, F Buyukkaya, DH Simsek, ZG Özkan, ... Clinical nuclear medicine 46 (8), 641-646, 2021 | 55 | 2021 |
| Diagnostic spectrum of congenital hypothyroidism in Turkish children M Tamam, I Adalet, B Bakır, C Türkmen, F Darendeliler, F Baş, Y Sanlı, ... Pediatrics International 51 (4), 464-468, 2009 | 54 | 2009 |
| Comparison of 68Ga-DOTATATE PET-CT, 18F-FDG PET-CT and 99mTc-(V) DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma ZG Ozkan, S Kuyumcu, AK Uzum, MF Gecer, S Ozel, F Aral, I Adalet Nuclear medicine communications 36 (3), 242-250, 2015 | 49 | 2015 |
| The value of somatostatin receptor imaging with In-111 octreotide and/or Ga-68 DOTATATE in localizing ectopic ACTH producing tumors ZG Özkan, S Kuyumcu, D Balköse, B Özkan, N Aksakal, E Yılmaz, Y Şanlı, ... Molecular Imaging and Radionuclide Therapy 22 (2), 49, 2013 | 45 | 2013 |
| Evidence of prostate-specific membrane antigen expression in hepatocellular carcinoma using 68Ga-PSMA PET/CT S Kuyumcu, D Has-Simsek, R Iliaz, Y Sanli, F Buyukkaya, F Akyuz, ... Clinical nuclear medicine 44 (9), 702-706, 2019 | 40 | 2019 |
| Survival analysis of Y‐90 radiosynovectomy in the treatment of haemophilic synovitis of the knee: a 10‐year retrospective review C Turkmen, O Kilicoglu, F Dikici, F Bezgal, S Kuyumcu, O Gorgun, ... Haemophilia 20 (1), e45-e50, 2014 | 38 | 2014 |
| Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET/CT according to ΔSUVmax, Deauville 5-point scale and IHP criteria EG Isik, S Kuyumcu, R Kebudi, Y Sanli, Z Karakas, FB Cakir, SN Unal Annals of nuclear medicine 31, 660-668, 2017 | 31 | 2017 |
| Fibroblast-activated protein inhibitor PET/CT: cancer diagnosis and management S Kuyumcu, Y Sanli, RM Subramaniam Frontiers in oncology 11, 758958, 2021 | 28 | 2021 |
| Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis ZG Ozkan, A Poyanli, A Ucar, S Kuyumcu, F Akyuz, S Keskin, S Saglam, ... Cancer Biotherapy and Radiopharmaceuticals 30 (3), 132-138, 2015 | 25 | 2015 |
| Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer? DH Simsek, Y Sanli, C Civan, MN Engin, EG Isik, ZG Ozkan, S Kuyumcu Annals of Nuclear Medicine 34, 476-485, 2020 | 24 | 2020 |
| Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings S Kuyumcu, I Adalet, Y Sanli, C Turkmen, ZG Ozkan, D Yilmazbayhan Annals of nuclear medicine 26, 689-697, 2012 | 22 | 2012 |
| Fibroblast activation protein–targeted PET imaging of metastatic castration-resistant prostate cancer compared with 68Ga-PSMA and 18F-FDG PET/CT EG Isik, D Has-Simsek, O Sanli, Y Sanli, S Kuyumcu Clinical nuclear medicine 47 (1), e54-e55, 2022 | 20 | 2022 |
| Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results S Kuyumcu, EG Isik, TO Tiryaki, D Has-Simsek, Y Sanli, F Buyukkaya, ... Annals of nuclear medicine 35 (10), 1147-1156, 2021 | 20 | 2021 |
| Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT Y Sanli, B Bakir, S Kuyumcu, ZG Ozkan, M Gulluoglu, O Bilge, C Turkmen, ... Clinical Nuclear Medicine 37 (7), 697-698, 2012 | 20 | 2012 |
Cuneyt Turkmenİstanbul Üniversitesi, İstanbul Tıp FakültesiVerified email at istanbul.edu.tr
